Next Article in Journal
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
Next Article in Special Issue
The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
Previous Article in Journal
Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges
Previous Article in Special Issue
BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
 
 

Order Article Reprints

Journal: Cancers, 2022
Volume: 14
Number: 110

Article: Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma
Authors: by Anna M. Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, Anna Szumera-Ciećkiewicz, Katarzyna Kozak, Tomasz Świtaj, Paweł Rogala, Iwona Kalinowska, Hanna Koseła-Paterczyk, Konrad Zaborowski, Paweł Teterycz, Andrzej Tysarowski, Donata Makuła and Piotr Rutkowski
Link: https://www.mdpi.com/2072-6694/14/1/110

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop